Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Source link
Read moreCirculation: Cardiovascular Quality and Outcomes, Ahead of Print. Source link
Read moreSee Editorial by Ardati et al Acute ST-segment–elevation myocardial infarction (STEMI) is a disease of high mortality and morbidity, and
Read moreSee Article by Tam et al The ongoing coronavirus disease 2019 (COVID-19) outbreak is poised to challenge populations and healthcare
Read moreAortic regurgitation The degree of aortic regurgitation (insufficiency) reported closest to incision but not >6 mo before surgery • Aortic
Read moreSee Article by Inohara et al Transcatheter aortic valve replacement (TAVR) has cemented itself as standard-of-care in the treatment of
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/4″>Volume 13, Issue 4</a>, April 1, 2020. Source link
Read moreWhat Is Known Transcatheter aortic valve replacement is recognized as an established therapeutic strategy for treating severe aortic stenosis and
Read moreDavid L. Morales Department of Pediatrics (J.L.J., R.B., A.L., C.C., D.L.M.), University of Cincinnati College of Medicine, OH Department of
Read moreCirculation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/13/4″>Volume 13, Issue 4</a>, April 1, 2020. Source link
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/4″>Volume 13, Issue 4</a>, Page e007043, April 1, 2020. Source link
Read more